DefiniGEN

DefiniGEN

DefiniGEN

A University of Cambridge company providing functional human cell products & services to the life science, drug discovery, and regenerative medicine sectors
Founded
2012
Raised
$6.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
£1,500,000
Venture capital (Series B) - 2016
University of Cambridge Enterprise Parkwalk Advisors Ltd
Team Size
1–10
Employees
£1,500,000 Venture capital (Series B)
BioPortfolio

DefiniGEN Raises £1.5M ($2.29M USD) in Follow-on Funding

Health Funding